Marker Therapeutics, Inc. (MRKR) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 17.43M | 19.07T | 21.73M | 14.77M | 16.99M | 22.02M | 10.91M | 11.68M | 14.09M | 17.13M | 19.49M | 21.96M | 10.91M | 16.62M | 22.42M | 29.28M | 31.02M | 45.98M | 51.41M | 60.02M |
| Cash & Short-Term Investments | 14.92M | 16.07T | 17.59M | 10.46M | 13.69M | 19.19M | 9M | 7.8M | 11.32M | 15.11M | 17.47M | 18.12M | 6.4M | 11.78M | 18.08M | 25.82M | 28.64M | 42.35M | 48.71M | 57.22M |
| Cash Only | 14.92M | 16.07T | 17.59M | 10.46M | 13.69M | 19.19M | 9M | 7.8M | 11.32M | 15.11M | 17.47M | 18.12M | 6.4M | 11.78M | 18.08M | 25.82M | 28.64M | 42.35M | 48.71M | 57.22M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.38M | 1.37M | 1.67M | 1.67M | 2.46M | 2.35M | 744.41K | 2.49M | 1.85M | 1.03M | 83.31K | 1.75M | 2.08M | 2.4M | 1.68M | 627.63K | 2.19K | 237 | 243 | 286 |
| Days Sales Outstanding | - | - | 124.59 | 218.37 | 619.43 | 63.15 | 77.25 | 168.95 | 105.31 | 48.38 | 326.67 | 228.44 | 163.5 | 247.41 | 106.24 | 36.25 | 0.11 | 0.02 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.14M | 3T | 2.48M | 1.35M | 841.29K | 0 | 0 | 1.38M | 917.01K | 0 | 1.93M | 2.09M | 0 | 585.84K | 0 | 0 | 181.86K | 1.15M | 0 | 0 |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.03M | 17.8M | 18.69M | 23.04M | 23.94M | 22.15M | 20.53M | 20.45M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.03M | 17.8M | 18.69M | 23.04M | 23.94M | 22.15M | 20.53M | 20.45M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | 0.07x | 0.04x | 0.05x | 0.03x | 0.04x | 0.06x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 143 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 17.43M | 19.07T | 21.73M | 14.77M | 16.99M | 22.02M | 10.91M | 11.68M | 14.09M | 17.13M | 19.49M | 21.96M | 27.94M | 34.42M | 41.11M | 52.32M | 54.96M | 68.14M | 71.94M | 80.47M |
| Asset Turnover | - | - | 0.07x | 0.05x | 0.02x | 0.14x | 0.17x | 0.09x | 0.08x | 0.06x | 0.01x | 0.03x | 0.04x | 0.02x | 0.02x | 0.01x | 0.02x | 0.02x | - | - |
| Asset Growth % | 2.59% | 86596268.5% | 99.21% | 26.49% | 20.59% | 28.58% | -44.01% | -46.82% | -49.57% | -50.24% | -52.6% | -58.04% | -49.16% | -49.48% | -42.85% | -34.98% | -37.81% | 49.37% | 48.11% | 65.84% |
| Total Current Liabilities | 3.64M | 2.27T | 3.35M | 4.28M | 2.5M | 3.46M | 3.46M | 1.97M | 2.3M | 3.07M | 2.78M | 2.92M | 5.2M | 7.78M | 11.29M | 13.47M | 8.21M | 12.9M | 8.23M | 5.66M |
| Accounts Payable | 1.5M | 793.73K | 951K | 1.72M | 1.3M | 1.07M | 1.9M | 1.08M | 848.03K | 961K | 429.1K | 1.33M | 2.86M | 1.1M | 2.02M | 1.77M | 5.02M | 5.14M | 2.33M | 2.04M |
| Days Payables Outstanding | - | - | - | 32.81 | 33.91 | 26.86 | 39.57 | 37.6 | 31.97 | 24.43 | 39.57 | 80.23 | 52.83 | 65.81 | 48.51 | 105.55 | 548.05 | 418.95 | 249.52 | 228.42 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 723.14K | 974.8B | 1.35M | 1.35M | 0 | 0 | 0 | 0 | 0 | 0 | 107.53K | 0 | 0 | 2.5M | 5.05M | 8M | 181.86K | 1.15M | 0 | 0 |
| Other Current Liabilities | 1.36M | 1.3T | 978.96K | 64.87K | 44.07K | 86.95K | 203.34K | 775.24K | 1.04M | 57.19K | 1.87M | 980.9K | 1.22M | 2.93M | 2.31M | 1.57M | 746.68K | 3.94M | 1.47M | 1.1M |
| Current Ratio | 4.79x | 8.39x | 6.50x | 3.45x | 6.79x | 6.36x | 3.15x | 5.92x | 6.12x | 5.57x | 7.01x | 7.52x | 2.10x | 2.14x | 1.99x | 2.17x | 3.78x | 3.56x | 6.25x | 10.61x |
| Quick Ratio | 4.79x | 8.39x | 6.50x | 3.45x | 6.79x | 6.36x | 3.15x | 6.62x | 6.12x | 5.57x | 7.01x | 7.52x | 2.10x | 2.14x | 1.99x | 2.17x | 3.78x | 3.56x | 6.25x | 10.61x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.82M | 7.04M | 7.23M | 10.82M | 11.04M | 11.25M | 11.43M | 11.57M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.82M | 7.04M | 7.23M | 10.82M | 11.04M | 11.25M | 11.43M | 11.57M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.64M | 2.27T | 3.35M | 4.28M | 2.5M | 3.46M | 3.46M | 1.97M | 2.3M | 3.07M | 2.78M | 2.92M | 12.03M | 14.82M | 18.51M | 24.29M | 19.25M | 24.15M | 19.66M | 17.23M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.49M | 7.62M | 7.72M | 11.56M | 11.72M | 11.87M | 12.01M | 12.13M |
| Net Debt | -14.92M | -16.07T | -17.59M | -10.46M | -13.69M | -19.19M | -9M | -7.8M | -11.32M | -15.11M | -17.47M | -18.12M | 1.09M | -4.17M | -10.36M | -14.26M | -16.92M | -30.48M | -36.69M | -45.09M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | 0.47x | 0.39x | 0.34x | 0.41x | 0.33x | 0.27x | 0.23x | 0.19x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 13.8M | 16.8T | 18.39M | 10.49M | 14.49M | 18.56M | 7.45M | 9.7M | 11.79M | 14.05M | 16.71M | 19.03M | 15.91M | 19.6M | 22.6M | 28.03M | 35.71M | 43.99M | 52.28M | 63.24M |
| Equity Growth % | -4.8% | 90507748.57% | 146.84% | 8.12% | 22.93% | 32.06% | -55.41% | -49.03% | -25.92% | -28.31% | -26.08% | -32.08% | -55.43% | -55.44% | -56.77% | -55.68% | -50.75% | 60.86% | 70.87% | 83.24% |
| Book Value per Share | 0.71 | 999999.00 | 1.10 | 0.75 | 1.30 | 2.04 | 0.83 | 1.09 | 1.32 | 1.58 | 1.89 | 2.16 | 1.82 | 2.33 | 2.70 | 3.35 | 4.30 | 5.29 | 6.29 | 7.62 |
| Total Shareholders' Equity | 13.8M | 16.8T | 18.39M | 10.49M | 14.49M | 18.56M | 7.45M | 9.7M | 11.79M | 14.05M | 16.71M | 19.03M | 15.91M | 19.6M | 22.6M | 28.03M | 35.71M | 43.99M | 52.28M | 63.24M |
| Common Stock | 16.67K | 16.67B | 16.67K | 11.31K | 11.21K | 10.71K | 8.92K | 8.92K | 8.91K | 8.89K | 8.89K | 8.8K | 8.8K | 8.41K | 83.6K | 83.6K | 83.45K | 83.08K | 83.08K | 83.08K |
| Retained Earnings | -462.36M | -459.18T | -457.48M | -455.48M | -451.46M | -447.02M | -443.18M | -440.87M | -438.68M | -436.29M | -433.48M | -430.5M | -433.02M | -428.05M | -424.19M | -417.27M | -408.03M | -398.12M | -388.36M | -375.93M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |